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Based on data from the Dutch Central Bureau of Statistics, the impact of influenza on mortality in The Netherlands was
estimated for a 22.5-year period (1967-1989) in four age groups and three entities of disease, using Poisson regression
techniques. Our analysis suggests that, on average, more than 2000 people died from influenza in The Netherlands
each year, but in only a fraction of these deaths was influenza recognized as the cause of death. For each case of
death registered as caused by influenza (registered influenza mortality), 2.6 additional cases of death registered as due
to causes other than influenza, nevertheless, were influenza-related (non-registered influenza mortality). Therefore, the
overall impact of influenza on mortality is estimated to be greater than registered influenza mortality by a factor of 3.6.
Those under 60 years of age accounted for 5% of all non-registered influenza deaths, whereas people aged 60-69,
70-79 years and >80 years accounted for 12%, 29% and 54% of such deaths, respectively. When extrapolating the
figures for the Dutch population of 1989, we could attribute, on average per season-year, 82 deaths per 100000 people
>60 years, 143 In people >70 years, and 280 in people >80 years. Of all non-registered influenza cases of death, 47%
were estimated to occur in people with heart disease as a primarily reported cause of death, 23% in those with lung
disease, and 30% in those with other diseases. This study stresses the serious effects of influenza, mainly in the elderly
(95% of non-registered influenza mortality). Prophylactic measures (vaccination) should not only be stimulated among
populations with defined underlying diseases, but generally among all people -"60 years. Future research should
address the pathological mechanisms which lead to influenza-related excess mortality.
The founder of modern concepts of medical
surveillance, William Farr, first introduced the notion
of 'excess mortality' in 1847.1 Since then studies from
several countries have shown that influenza is one of
the most important causes of excess mortality and that
influenza mortality in non-pandemic seasons mainly
occurs in the elderly.2'3
Infection by influenza A and B viruses and its com-
plications can now be prevented effectively by vac-
cination.*-* However, it is well-known that this simple
preventive measure is not used optimally.7'8 To increase
influenza prevention, and to develop an effective vac-
cination policy, it is important to define high-risk sub-
populations and to demonstrate the quantitative
impact of influenza mortality on the national level.
In a previous paper, describing data from The
Netherlands in the period 1967-1982, we showed that,
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on average, in 50 cases per 100000 subjects > 70 years,
the cause of death was registered on the death certifi-
cates as being 'influenza' (registered influenza mor-
tality f. In another 140 cases, the cause of death was
registered as not 'influenza' but was nevertheless
related to influenza (/ton-registered influenza mortal-
ity). This study analyses the non-registered influenza
mortality and establishes its distribution among sub-
populations defined by age and underlying medical
conditions, using a comprehensive regression model to
relevant data obtained from the Dutch Central Bureau
of Statistics for an extended period (1967-1989). This
particular period was chosen to counterbalance
seasons with unusual high and unusual low influenza
activity. The emergence of influenza subtype A-H3N2
in 1968 and subtype A-H1N1 in 1977 lie within the
study period.
MATERIALS AND METHODS
Sources
Relevant data were obtained from the Dutch Central
Bureau of Statistics (CBS, Mndber gezondheid) for the
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period January 1967 to June 1989 (22.5 years). Of the
data from death certificates, only the 'primary cause
of death' was used. Deaths were entered by date of
death, not by date of report.
Definition of Epidemiological Measures
Influenza activity. As a surrogate marker for the
influenza activity in the total population, the monthly
mortality based on 'primary cause of death: influ-
enza', i.e, code 487 of the International Classification
of Diseases (ICD) 9th revision, was used (registered in-
fluenza mortality). In contrast to other studies, deaths
registered as due to 'pneumonia' were not included. As
many cases of pneumonia are not caused by influenza
viruses, it was expected that including pneumonia
would have produced more unwanted residual vari-
ance in the statistical model. In this study data on
morbidity (occurrence of influenza-like illnesses) or
virological criteria (influenza virus isolates) were not
used to define influenza activity; nevertheless in an
earlier study, we have found a good correlation be-
tween influenza mortality and reported cases of
influenza-like illness.10
Mortality in (sub)populations. The measure of mor-
tality was the observed monthly number of deaths for
the total population or each subpopulation. Sub-
populations were distinguished according to age or
disease entity.
Four age groups were defined as 0-59, 60-69, 70-79,
and ^ 80 years. Thus, the analysis focused on the
elderly in whom excess mortality was mainly expected
to occur. We recognized that young children (< 5
years) might also be of interest, but because of the lack
of virological data on other respiratory pathogens, in
particular respiratory syncytial virus, that subpopula-
tion was not analysed.
Three entitites of disease as reported to be the
primary cause of death other than influenza were
distinguished: heart disease, lung disease, and all other
diseases. Table 1 shows the corresponding ICD
numbers during the period 1967-1989. This study does
not address possible differences in mortality within
disease entities.
Statistical Model
The statistical model (multivariate regression) ad-
dressed the relationship between mortality in the total
population or in defined subpopulations (dependent
variable), and influenza activity in the total popula-
tion, calendar month, calendar year and (sub)popula-
tion size (independent variables). The relevant model
parameters were estimated by means of a Poisson
TABLE 1 Identification of ICD codes 7th, 8th and 9th revision, with
influenza, heart disease and lung disease
ICD revision
Heart disease
Chronic rheumatic heart disease
Hypertensive disease
Ischaemic heart disease
Other forms of heart disease
Cerebrovascular Disease
Lung disease
Pneumonia
Bronchitis, emphysema, asthma
Influenza
7th
410-416
440-447
420-422
430-434
450-468
782
330-334
490-493
500-502
480-483
8th
393-398
401^105
410-414
420-429
440-458
450^(59
430-438
480^86
489-493
470
9th
393-398
401-405
410-414
415-417
420-429
440-448
451-459
430-438
480-486
490-493
487
regression analysis using the GLIM system,""13 with
the relevant (sub)population group sizes as multi-
pliers. Details of the statistical model are given in the
Appendix.
To calculate non-registered influenza mortality,
overall mortality in a (sub)population was fitted to in-
fluenza activity in the total population, adjusting for
seasonal and long-term fluctuations by including
month and year effects in the model. The effect of in-
fluenza was then eliminated by setting the influenza ac-
tivity in the model at zero keeping the effects of year
and month the same. The difference between the
predicted mortality in the situation of observed in-
fluenza activity and the predicted mortality in the
absence of influenza activity was defined as the non-
registered influenza mortality.
RESULTS
Non-Registered Influenza Mortality in the Entire
Population
Figure 1 shows the overall mortality based on all
registered causes of death with the exception of
'influenza', either predicted from the regression equa-
tion (dotted line), or observed (unbroken line), per
calendar month. The overall trend is upwards because
of population increase during the reported period. In
1967 the total population was about 12.5 million
people, in 1989 14.8 million.
Figure 2 presents the predicted mortality in Figure 1
(dotted line), compared to the simulated situation of
absent influenza activity (unbroken line). The dif-
ference between these two lines represents the non-
registered influenza mortality. It is often said that
people suffering from heart or lung diseases who die
during influenza epidemics, would otherwise have died
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FIGURE 1 Observed and predicted total monthly mortality (excluding Influenza) in the period 1967-1989 in The Netherlands. Unbroken
line: observed mortality; dotted line: predicted mortality from the regression equation.
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FIGURE 2 Predicted total mortality (excluding influenza) assuming presence (dotted line) or absence (unbroken line) of influenza
activity, in the period 1967-1989 in The Netherlands per month.
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a few weeks later. If this were so there would be a
decrease in mortality immediately following an in-
fluenza epidemic. We did not observe such a time-lag
in our monthly data. Whether a time-lag would be
detectable when analysing weekly data, is a matter for
conjecture.
Figure 3 shows the sum of registered influenza mor-
tality and non-registered influenza mortality per
season-year (July until June), per million people > 60
years. In almost every year influenza mortality is pre-
sent. The proportion of registered and non-registered
influenza mortality of the predicted total mortality
based on all causes of death is calculated. For
February 1970, it was 24%; i.e. 24% of the total mor-
tality in February 1970 was associated with influenza.
The absolute number of registered influenza deaths
equals 9710 in The Netherlands for the period studied.
The number of excess deaths associated with influenza
activity (non-registered influenza deaths) was esti-
mated to be 25101. The global ratio of registered/
non-registered influenza mortality was 2.6; i.e. for
every influenza death officially registered, there were,
on average, 2.6 additional non-registered influenza
deaths. Hence, the overall impact of influenza on mor-
tality is estimated to be 3.6 times greater than
registered influenza mortality.
Non-Registered Influenza Mortality According to Age
Table 2 displays the registered and non-registered in-
fluenza mortality by age group per year. On average,
only 5% of non-registered influenza deaths occurred in
people <60 years, whereas 12% occurred in those of
60-69, 29% in those of 70-79, and 54% in those aged
>80 years. However, these proportions also depend
on the relative sizes of these age groups in the popula-
tion. The absolute number of both registered and non-
registered influenza mortality in people >60 was
estimated to be 2100 per season-year. If the figures are
extrapolated to the whole population of 1989, 82
deaths per 100000 per season-year in people > 60 years
can be attributed to influenza, 143 in people > 70 years
and 280 in people > 80 years.
Non-Registered Influenza Mortality According to
Disease Entity
Of non-registered influenza deaths 47% were estimated
to have occurred in people with heart disease, and 23%
in those with lung disease. The remaining 30% of non-
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FIGURE 3 Registered and non-registered influenza mortality per million people > 60 years per season-year in the period
1967-1989 in The Netherlands.
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TABLE 2 Registered influenza and non-registered mortality per age group in The Netherlands as a yearly average of the study for the period
1967-1989
Age group > 60 yean > 70 years ^80 years
Population in The Netherlands 1989 x 10* (c)
Registered influenza mortality per 10s (a)
Non-registered influenza mortality per 10s (b)
Registered and non-registered influenza mortality per 105 (a + b)
Total registered and non-registered influenza related mortality in
The Netherlands ([a + b)c)
2.546
22
60
82
1.264
41
102
143
0.418
89
W
280
2091 1805 1170
registered influenza deaths were classified as 'other
mortality'.
Figure 4 shows the total (registered and non-
registered) influenza mortality by disease entity per age
group. For each entity, the majority of total influenza
deaths occurred in people > 60 years. Those < 60 years
accounted for only 5°7o of these deaths. Among all
three older groups, there were no appreciable dif-
ferences in mortality from the four diagnostic
categories.
DISCUSSION
Our analysis suggests that, on average, more than 2000
people died from influenza in The Netherlands each
year of the study, but in only a fraction of these
deaths, was it recognized as the cause of death. For
every registered influenza death, there were 2.6 ad-
ditional non-registered influenza deaths. This non-
registered mortality predominated amongst the
elderly. Almost half of these cases were registered as
death from heart disease, approximately 25 "Io from lung
disease, and approximately 30% from other diseases.
It is likely that our estimate of the impact of influenza
epidemics was conservative because some elderly and
other high-risk people received influenza vaccine prior
to each of the epidemics included in the study.
It is appreciated that the statistical model and
mathematical simulation cannot provide proof of a
causal relationship between influenza infection and
non-registered influenza mortality. However, the coin-
cidence in time, and the strong statistical correlation,
of influenza activity and non-registered influenza mor-
tality in our study are striking.
Optimally, also virological data such as annual
number and taxonomy of isolates, should be included
in the model. This would require a continuous sur-
veillance system with constant measures and a constant
denominator during the entire study period. These
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FIGURE 4 Total (registered and non-registered) influenza mortality per entity of disease per age group in the
period 1967-1989 in The Netherlands.
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data were not available in Europe for the period
reported. To improve the model by including viro-
logical data, a new surveillance system will be
established in The Netherlands in 1992-1993 season.
Excess mortality in The Netherlands was found to be
lower during the period 1967—1978 compared with
1979-1989. It is tempting to relate this fact to the re-
occurrence of the influenza A-H1N1 subtype in 1977
and its concurrence with the A-H3N2 subtype since
then. The A-H1N1 subtype has caused mortality
predominantly in subpopulations born after 1957
when A-H1N1-strains had ceased circulating; there-
fore, its contribution to excess mortality in the
elderly may have been low or absent, and total excess
mortality decreased. However, in the US, excess mor-
tality was higher during the 1985-1986 season than in
any other single season since 1968-1969.14 We are
unable to explain this geographical discrepancy.
In Farr's original study, almost 150 years ago, the
total excess mortality from all causes was ascribed to
the occurrence of an influenza epidemic.1 He proposed
a method that was based on the calculated expectancy
of 'mortality for the season' and estimated that ap-
proximately 45% of the total mortality during the in-
fluenza epidemic period was related to influenza. In
our study we estimated the maximum effect of influ-
enza on total mortality to be 24% (1969-1970). For
each influenza death registered according to Farr, a
further 3.5 deaths were associated with influenza, in
contrast to our estimate of 2.6 additional deaths. The
difference between our findings and Farr's may be due
to characteristics of the epidemics, improved sanitary
conditions, the availability of antibiotics and influ-
enza vaccine, and refinements in our model, which
take into account both long-term and seasonal effects
over a period of 22.5 years.
During the last 25 years, a number of studies, ex-
clusively from the US and Great Britain have dealt
with excess influenza mortality.15"22 Although describ-
ing study periods which differ in length and
epidemiological characteristics, using various sur-
rogate measures for influenza, and applying diverse
statistical methods, they all agree in establishing the
huge impact of influenza activity on excess mortality.
Interestingly, some quantitative differences can be
found. For example, the proportion of the elderly (^65
years) among total excess mortality was reported to be
65% by Clifford et a/.16 88% by Tillett et al.{1 73% by
Ailing et al.xt and 80-90% by Lui and Kendal.22 In our
study, this proportion (in those aged Js60 years) is
higher (95%). Choi and Thacker2324 used the
autoregressive integrated moving average (ARIMA)
model of Box and Jenkins23 to estimate excess mortal-
ity. This method uses the dynamics in the weekly
figures of an observed time series in order to make
forecasts. In our monthly figures, however, only small
(<0.25) serial correlations were found in the residuals
from the estimated model. We also covered the longest
study period (22.5 years) which may have counter-
balanced seasons with atypical epidemiology, and
described influenza mortality in a continental Euro-
pean country where influenza epidemiology might be
slightly different from Northern America or Great
Britain.
In The Netherlands, health authorities only consider
people with established underlying chronic disease to
be at high risk of dying from influenza. However, our
results, in agreement with studies from other coun-
tries, suggest that for all those aged ^60 years in
general, vaccination should be recommended, to
reduce influenza mortality. This will become even
more important in the future, when the proportion of
the elderly in the population, and consequently the
cost of medical care increases.26"29
Investigations of excess influenza mortality should
be continued in future. Of special interest could be the
exact pathological mechanisms underlying the excess
mortality in the subpopulation with heart disease.
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particular cause (influenza excluded) in a certain sub-
population of size Nj is assumed to be a Poisson-
distributed random variable with mean and variance
equal to a parameter X, specified as:
12 K
\ = N,-exp (E
j - i
[j + i P k J k + ygFi)
k-2
i = 1.....I monthly figures
N| = size of the subpopulation considered in month i
M j = 1 for calendar month j
= 0 elsewhere
j = 1,..., 12 (January-December)
Jk = 1 for the k-th calendar year considered
= 0 elsewhere
(basis is first calendar year considered)
k = 2.....K
Ft = influenza activity indicator in month i
The coefficients a^ Pk and yg have to be estimated.
The coefficient y represents the effects of the in-
fluenza activity in the total population on mortality
from a certain cause other than influenza in a certain
subpopulation. The quantity l-exp^yF,) represents
the excess mortality in month i as proportion of X,. As
a first approach to measure influenza activity, F, is
defined as the influenza mortality rate per month dur-
ing the period January 1967 to June 1989 in the total
population.
The above model is only specified for one death
cause category and one subpopulation considered. In
order to indicate the various death cause categories
and subpopulations (age groups) considered two more
indices are necessary: d for death cause category
(d = 1.....D) and p for subpopulation (p = 1 P).
In the model the coefficients a, p" and y as well as the
expected number X should get additional indices d
and p:
ajdP- Pkpo. Ydp and X.,dp
The size N of the subpopulation considered should
only get an additional index p: Nip.
Hence, the model becomes:
12 K
APPENDIX
During an observation period of I months i = 1.....I
the monthly observed number of deaths from a
J - l
for the d-th death cause category (d = 1.....D)
and the p-th subpopulation (p = 1.....P)
